Oct 30 (Reuters) - Oriola Oyj OKDBV.HE :
* IN 2024, PHARMACEUTICAL DISTRIBUTION MARKET IS EXPECTED TO
CONTINUE TO GROW.
* EXPECTS ADJUSTED EBIT, EXCLUDING DOSE DISPENSING BUSINESS
IN
SWEDEN, FOR YEAR 2024 TO INCREASE FROM ADJUSTED EBIT FOR 2023
* RECENT OVERALL INFLATIONARY ENVIRONMENT AND RELATED COST
PRESSURES MAY HAVE AN IMPACT ON ORIOLA'S PROFITABILITY
* CONTINUATION OF A WEAK CONSUMER CONFIDENCE MIGHT IMPACT
WHOLESALE MARKET DEVELOPMENT.
Source text: ID:nWkr5c8yLQ
Further company coverage: OKDBV.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))